The UK’s medical cannabis market is expanding rapidly, with growth estimated at around 10% per month, according to Jon Robson, CEO of Mamedica, a leading medical cannabis clinic. Despite this impressive growth, access to medical cannabis remains largely confined to illicit channels and a limited private sector, as National Health Service (NHS) prescriptions remain highly restricted. Barriers To NHS PrescriptionsSince medical marijuana (MMJ) was legalized in the UK in 2018, around 50,000 patients have gained access to these treatments. However, NHS prescriptions are restricted to specific condi…
